At the time of writing, MapLight Therapeutics Inc [MPLT] stock is trading at $18.34, up 8.39%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The MPLT shares have gain 41.19% over the last week, with a monthly amount glided 12.93%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
MapLight Therapeutics Inc [NASDAQ: MPLT] stock has seen the most recent analyst activity on November 21, 2025, when Stifel initiated its Buy rating and assigned the stock a price target of $28. Previously, Morgan Stanley started tracking the stock with Overweight rating on November 21, 2025, and set its price target to $34. On November 21, 2025, Leerink Partners initiated with an Outperform rating and assigned a price target of $30 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $32 on November 21, 2025.
For the past year, the stock price of MapLight Therapeutics Inc fluctuated between $12.24 and $20.86. Currently, Wall Street analysts expect the stock to reach $31 within the next 12 months. MapLight Therapeutics Inc [NASDAQ: MPLT] shares were valued at $18.34 at the most recent close of the market. An investor can expect a potential return of 69.03% based on the average MPLT price forecast.
Analyzing the MPLT fundamentals
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 16.58 points at the first support level, and at 14.81 for the second support level. However, for the 1st resistance point, the stock is sitting at 19.53, and for the 2nd resistance point, it is at 20.71.
Ratios To Look Out For
It is important to note that MapLight Therapeutics Inc [NASDAQ:MPLT] has a current ratio of 4.89. In addition, the Quick Ratio stands at 4.89.
Transactions by insiders
Recent insider trading involved Novo Holdings A/S, 10% Owner, that happened on Oct 28 ’25 when 0.95 million shares were purchased. 10% Owner, Catalyst4, Inc. completed a deal on Oct 28 ’25 to buy 5.44 million shares.
